Linfoma primário do sistema nervoso central: relato de um caso tratado com sucesso empregando-se quimioterapia em doses elevadas e radioterapia subsequente
DOI:
https://doi.org/10.32635/2176-9745.RBC.1992v38n1.3069Palabras clave:
Linfoma, Sistema Nervoso CentralResumen
O esquema quimioterápico ideal para o tratamento dos línfornas primários do SNC é ainda objeto de investigações. O presente trabalho descreve um caso tratado com vincristina e doses elevadas de dexametasona, metotrexate e citosina arabinosfdeo (Ara-C), além de quimioterapia intratecal, que resultou na remissão completa do tumor. Uma revisão da literatura também é feita.
Descargas
Citas
ZIMMERMAN HM. Malignant lymphomas of the nervous system. Acta Neuropathol (BerI) 1975; 6(suppl.); 69-74. DOI: https://doi.org/10.1007/978-3-662-08456-4_11
EBY NI, GRUFFERMAN S. FLANNELLY CM, SCHOLD SC, VOGEL FS, BURGER PC. Increasing incidence of primary brain lymphoma in the US. Câncer 1988; 62; 2461-2465. DOI: https://doi.org/10.1002/1097-0142(19881201)62:11<2461::AID-CNCR2820621135>3.0.CO;2-M
O’NEILL BP, ILLIG JJ. Primary central nervous system lymphoma. Mayo Clin Proc 1989; 64: 1005-1020. DOI: https://doi.org/10.1016/S0025-6196(12)61228-2
MURRAY K, KUN L, COX J. Primary malignant lymphoma of the central nervous system: Results of treatment of 11 cases and review of the llterature. J Neurosurg 1986; 65:600-607. DOI: https://doi.org/10.3171/jns.1986.65.5.0600
BERRY MP, SIMPSON WJ. Radiation therapy in the management of primary malignant lymphoma of the brain. Int J Radiat Oncol Biol Phys1981; 7: 55-59. DOI: https://doi.org/10.1016/0360-3016(81)90060-2
NEUWELT EA, FRENKEL EP, GUMERLOCK ML, BRAZIEL R, DANA B, HILL SA. Developments in the diagnosis and treatment of primary CNS lymphoma. Câncer 1986; 58:1609-1620. DOI: https://doi.org/10.1002/1097-0142(19861015)58:8<1609::AID-CNCR2820580805>3.0.CO;2-7
SHIBAMOTO Y et al. Improved survival rate in primary intracranial lymphoma treated by high-dose radiation and systemic vincristine doxorrubicine-ciclophosphamide-prednisolone chemotherapy. Câncer 1990; 65; 1907-1912. DOI: https://doi.org/10.1002/1097-0142(19900501)65:9<1907::AID-CNCR2820650906>3.0.CO;2-L
DeANGELIS LM et al. Primary CNS lymphoma: Combined treatment with chemotherapy and radiotherapy. Neurology 1990; 40; 80-86. DOI: https://doi.org/10.1212/WNL.40.1.80
ERVIN T, CANELLOS GP. SuccessfuI treatment of recurrent primary central nen/ous system lymphoma with high-dose methotrexate. Câncer 1980; 45:1556-1557. DOI: https://doi.org/10.1002/1097-0142(19800401)45:7<1556::AID-CNCR2820450707>3.0.CO;2-B
FRICK JC, HANSEN RM, ANDERSON T, RICH PS. SuccessfuI high-dose intravenous cytarabine treatment of parenchymal brain involvement from malignant lymphoma. Arch Intern Med 1986; 146: 791-792. DOI: https://doi.org/10.1001/archinte.146.4.791
PITMAN SW, FREI III E. Weekly methotrexate-calcium leucovorim recue: Effect of alkalinization on nephrotoxicity; pharmacokinectics in the CNS; use in CNS non-Hodgkin’s lymphoma. Câncer Treat Rep 1977; 61:695.
